Morgan Stanley Hutchmed (China) LTD Put Options Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HCM
# of Institutions
63Shares Held
6.45MCall Options Held
9.9KPut Options Held
9.6K-
Schroder Investment Management Group London, X02.84MShares$37.2 Million0.05% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1MShares$13.1 Million0.02% of portfolio
-
State Street Corp Boston, MA337KShares$4.41 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.13 Million0.13% of portfolio
-
M&G PLC London, X0259KShares$3.39 Million0.03% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.26B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...